| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,440,000 | 1,319,000 | 1,302,000 | 1,465,000 | | Cost of Revenue | 1,124,000 | 1,116,000 | 1,123,000 | 1,254,000 | | | Gross Profit | 316,000 | 203,000 | 179,000 | 211,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (84,000) | (46,000) | 43,000 | 99,000 | | Non Recurring | 4,000 | 6,000 | 59,000 | 721,000 | | Others | 101,000 | 104,000 | 99,000 | 110,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 295,000 | 139,000 | (22,000) | (719,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 11,000 | | Earnings Before Interest And Taxes | 295,000 | 139,000 | (22,000) | (708,000) | | Interest Expense | 34,000 | 23,000 | 31,000 | 33,000 | | Income Before Tax | 261,000 | 116,000 | (53,000) | (741,000) | | Income Tax Expense | 78,000 | 68,000 | (8,000) | (65,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 183,000 | 48,000 | (45,000) | (676,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 183,000 | 48,000 | (45,000) | (676,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $183,000 | $48,000 | ($45,000) | ($676,000) |
|
0.50% Nasdaq 0.00%
Income Statement
